#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	17468	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2390	896.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1575	1575	C	1075	C,A	1072,3	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29654	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4095	902.4	0	.	n	.	0	T695C	SNP	695	695	T	1311	1311	C	1115	C,T,G,A	1109,3,1,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29654	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4095	902.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1953	1953	A	1176	A,C,G	1169,4,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29654	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4095	902.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2587	2587	C	1117	C,G,A	1113,2,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29654	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4095	902.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2661	2661	A	1028	A,C,G,T	1024,2,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29654	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4095	902.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	3213	3213	C	1043	C,T	1041,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2598	folP	855	855	100.0	folP.l15.c4.ctg.1	1925	168.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1200	1202	AGC	237;239;243	A;G;C	237;239;243	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6244	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3732	208.3	1	SNP	p	S91F	1	.	.	271	273	TTC	777	779	TTC	220;221;223	T;T;C	220;221;223	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6244	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3732	208.3	1	SNP	p	G95N	0	.	.	283	285	GGC	789	791	GGC	229;228;226	G;G,A;C	228;227,1;226	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6244	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3732	208.3	1	SNP	p	D95G	1	.	.	283	285	GGC	789	791	GGC	229;228;226	G;G,A;C	228;227,1;226	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	2300	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1869	153.5	1	SNP	p	G45D	0	.	.	133	135	GGC	727	729	GGC	273;276;277	G;G;C	273;276;277	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1274	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1307	120.4	0	.	n	.	0	A197.	DEL	197	197	A	662	662	A	248	A	248	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5838	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3556	204.6	1	SNP	p	D86N	0	.	.	256	258	GAC	805	807	GAC	252;252;251	G;A;C,T	252;252;250,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5838	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3556	204.6	1	SNP	p	R87W	0	.	.	259	261	CGT	808	810	CGT	251;251;253	C;G;T	251;251;253	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5838	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3556	204.6	1	SNP	p	S87R	1	.	.	259	261	CGT	808	810	CGT	251;251;253	C;G;T	251;251;253	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5838	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3556	204.6	1	SNP	p	R87I	0	.	.	259	261	CGT	808	810	CGT	251;251;253	C;G;T	251;251;253	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5838	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3556	204.6	1	SNP	p	S88P	0	.	.	262	264	TCC	811	813	TCC	252;255;251	T;C,G;C	252;254,1;251	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4850	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3098	194.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1863	1865	GGC	277;276;275	G;G,T,C;C	276;274,1,1;275	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4604	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2850	201.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1527	1529	GCA	259;258;261	GC,G;C;A,G	251,1;258;260,1	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4604	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2850	201.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1530	1532	ATC	261;260;257	A;T;C,G	261;260;256,1	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4604	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2850	201.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1542	1544	GTG	250;248;249	G;T;G	250;248;249	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4604	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2850	201.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1542	1544	GTG	250;248;249	G;T;G	250;248;249	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4604	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2850	201.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2046	2048	ACC	275;276;276	A,G;C,T;C	274,1;275,1;276	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4604	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2850	201.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2100	2102	GCG	267;268;264	G;C;G	267;268;264	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4604	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2850	201.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2100	2102	GCG	267;268;264	G;C;G	267;268;264	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4604	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2850	201.2	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2223	2225	AGC	236;238;237	A;G,C;C	236;237,1;236	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4604	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2850	201.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2232	2234	GGC	234;235;235	G;G;C	234;235;235	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4604	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2850	201.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2250	2252	CCG	237;237;234	C;C;G	237;237;234	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6342	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3616	218.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1902	1904	CCG	240;241;239	C;C;G	240;241;239	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2874	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2321	154.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	843	843	C	226	C	226	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	358	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	624	25.5	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	41;43;45	T;T;A	41;43;45	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	358	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	624	25.5	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	80;80;80	C;A;T	80;80;80	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	358	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	624	25.5	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	80;80;80	A;G;T	80;80;80	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	358	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	624	25.5	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	80;80;80	T;A;C	80;80;80	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	358	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	624	25.5	0	.	p	.	0	R307A	NONSYN	919	921	AGA	161	163	GCA	2;2;2	G;C;A	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	358	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	624	25.5	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	2;2;2	G;C;A	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	358	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	624	25.5	0	.	p	.	0	E312D	NONSYN	934	936	GAA	176	178	GAC	2;2;2	G;A;C	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	358	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	624	25.5	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	2;2;2	A;T;C	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	358	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	624	25.5	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	2;2;2	T;C;G	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	358	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	624	25.5	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	2;2;2	G;C;C	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	358	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	624	25.5	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	2;2;2	A;G;C	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	358	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	624	25.5	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	2;2;2	G;C;C	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	358	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	624	25.5	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	2;2;2	G;T;T	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	358	porB1a	984	100	95.0	porB1a.l15.c17.ctg.3	182	59.1	0	.	p	.	0	M18T	NONSYN	52	54	ATG	133	135	ACG	66;66;65	A;C;G	66;66;65	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	358	porB1a	984	100	95.0	porB1a.l15.c17.ctg.3	182	59.1	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	175	177	CAA	26;21;16	C;A;A	26;21;16	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3456	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1899	225.5	0	.	p	.	0	N38E	NONSYN	112	114	AAT	556	558	GAA	296;296;295	G,T;A;A	295,1;296;295	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3456	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1899	225.5	0	.	p	.	0	N134D	NONSYN	400	402	AAT	844	846	GAT	290;289;287	G;A,G;T,A	290;287,2;286,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3456	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1899	225.5	0	.	p	.	0	P175S	NONSYN	523	525	CCA	967	969	TCA	306;306;306	T;C;A	306;306;306	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3456	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1899	225.5	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1096	1098	GTC	277;276;270	G;T,C,G;C,A	277;273,2,1;269,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3456	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1899	225.5	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1426	1428	GCA	296;294;296	G,T,A;C;A,T	294,1,1;294;295,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3456	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1899	225.5	1	SNP	p	G120K	1	.	.	358	360	AAG	802	804	AAG	261;267;268	A;A;G	261;267;268	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3456	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1899	225.5	1	SNP	p	A121D	1	.	.	361	363	GAC	805	807	GAC	269;270;273	G;A,C;C	269;269,1;273	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3456	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1899	225.5	1	SNP	p	D121N	0	.	.	361	363	GAC	805	807	GAC	269;270;273	G;A,C;C	269;269,1;273	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10994	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5314	257.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1606	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1538	130.3	1	SNP	p	V57M	1	.	.	169	171	ATG	734	736	ATG	277;276;275	A;T;G,T	277;276;274,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
